FDA Passes on Olorofim Despite Critical Need for Antifungals FDA Passes on Olorofim Despite Critical Need for Antifungals

It is hard to hurt fungus without being toxic to other human cells, point out infectious disease experts, who say they urgently need new treatment options.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Infectious Diseases News Source Type: news